Back
Corporate News
Aurobindo Pharma’s board approved a 700% interim dividend for the financial year 2026-27
05-Nov-2026, 12:21
Aurobindo Pharma Limited’s board of directors approved an interim dividend of 700%, or Rs 7.00 per equity share, for the financial year 2026-27, with November 11, 2026, set as the record date and payment expected on or before November 20, 2026.
